Followers | 244 |
Posts | 12271 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |

Monday, February 19, 2024 1:44:30 PM
This marks the final regulatory approval needed in the acquisition process
IRVING, Texas, Feb. 19, 2024 /PRNewswire/ -- Vistra (NYSE: VST) has now received approval from the Federal Energy Regulatory Commission (FERC) to acquire Energy Harbor.
Vistra announced last March that the purchase of Energy Harbor, which includes a 4,000-megawatt nuclear generation fleet and retail business of ~1 million customers, presents a unique opportunity to accelerate the growth of Vistra's zero-carbon generation portfolio.
FERC's approval, which was received Friday afternoon, was the last regulatory approval needed for the companies to close the transaction.
Vistra anticipates closing in the coming weeks.
About Vistra
Vistra (NYSE: VST) is a leading Fortune 500 integrated retail electricity and power generation company based in Irving, Texas, providing essential resources for customers, commerce, and communities. With operations in 20 states and the District of Columbia, Vistra combines an innovative, customer-centric approach to retail with safe, reliable, and efficient power generation. Learn more at vistracorp.com.
https://www.prnewswire.com/news-releases/vistra-receives-approval-from-federal-energy-regulatory-commission-on-energy-harbor-acquisition-302065005.html
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, Founder and CEO of Harwood International
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM